Tim’s 25 year career in biotechnology, cell therapy and medical device general management includes experience as a founder of three start-up companies as well as senior executive assignments at two of Massachusetts’ top 20 healthcare companies. In these roles he has had extensive line management experience with a particular focus on business development transactions, new product development and launch, investor relations and corporate finance.
Prior to founding Red Sky Partners in early 2009, Tim was President and CEO of Cyberkinetics NeuroTechnology Systems, Inc. His previous positions include EVP of Haemonetics Corporation, President of Genzyme Tissue Repair, the cell therapy division of Genzyme Corporation, and EVP and CFO of BioSurface Technology. Tim serves on the Board of Directors of NeuroMetrix, Inc., a medical device company, and the Charles River School in Dover, MA. Tim received a B.A. in Biochemistry from Williams College and an M.B.A. from Harvard Business School.